SOPHARMA AD: Unipharm AD is now merged into Sopharma AD

opublikowano: 2018-09-13 16:55

Spis treści:

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
Notification_transformation_through_merger_Unipharm_espi.pdf (REPORT)

	POLISH FINANCIAL SUPERVISION AUTHORITY
				UNI - EN REPORT No		91	/	2018
	Date of issue:		2018-09-13
	Short name of the issuer
	SOPHARMA AD
	Subject
	Unipharm AD is now merged into Sopharma AD
	Official market - legal basis
	art. 56. 1. 2 of Act on Public Offering.
	Unofficial market - legal basis
	Contents of the report:
	Sopharma AD notifies that the procedure for merger of Unipharm AD into Sopharma AD finished today with an entry in the Commercial register number 20180913171143. Sopharma AD will take actions to deregister Unipharm AD from the list of public companies and from the BSE – Sofia AD, to register the new shareholders in the Central Depository and to register the merger into the Registry agency.
	Annexes
	File				Description
	Notification_transformation_through_merger_Unipharm_espi.pdfNotification_transformation_through_merger_Unipharm_espi.pdf				Unipharm AD is now merged into Sopharma AD

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

16

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

	SIGNATURE OF PERSONS REPRESENTING THE COMPANY
	Date	Name	Position / Function	Signature
	2018-09-13	Ognian Donev	Executive director